Cite
TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α.
MLA
Cheng, Kai, et al. “TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α.” Journal of Interferon & Cytokine Research, vol. 43, no. 11, Nov. 2023, pp. 495–511. EBSCOhost, https://doi.org/10.1089/jir.2023.0088.
APA
Cheng, K., Jia, Q., Batbatan, C., Guo, Z., & Cheng, F. (2023). TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α. Journal of Interferon & Cytokine Research, 43(11), 495–511. https://doi.org/10.1089/jir.2023.0088
Chicago
Cheng, Kai, Qingmei Jia, Christopher Batbatan, Zhihua Guo, and Fengtao Cheng. 2023. “TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α.” Journal of Interferon & Cytokine Research 43 (11): 495–511. doi:10.1089/jir.2023.0088.